Aatmaja Healthcare Ltd Stock Price Today (NSE: AATMAJ)
Fundamental Score
Aatmaja Healthcare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Aatmaja Healthcare Ltd share price today is ₹18.25, down 1.62% on NSE/BSE as of 1 September 2026. Aatmaja Healthcare Ltd (AATMAJ) is a Small-cap company in the Hospital sector with a market capitalisation of ₹43.73 (Cr). The 52-week high for AATMAJ share price is ₹25.50 and the 52-week low is ₹16.70. At a P/E ratio of 61.59x, AATMAJ is currently trading above its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 1.41% and a debt-to-equity ratio of 0.41.
Aatmaja Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance
Aatmaja Healthcare Ltd share price chart: 4.11% return over the past month. 52-week high ₹25.50, 52-week low ₹16.70.
Aatmaja Healthcare Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹18.05 | ₹18.50 | ₹18.05 | ₹18.50 | 4.00K (Cr) | |
| ₹20.50 | ₹20.50 | ₹19.00 | ₹19.00 | 10.00K (Cr) | |
| ₹18.05 | ₹18.10 | ₹18.05 | ₹18.10 | 4.00K (Cr) | |
| ₹18.60 | ₹18.60 | ₹18.60 | ₹18.60 | 2.00K (Cr) | |
| ₹17.85 | ₹18.55 | ₹17.80 | ₹18.55 | 16.00K (Cr) | |
| ₹19.00 | ₹19.00 | ₹18.80 | ₹18.80 | 6.00K (Cr) | |
| ₹19.95 | ₹19.95 | ₹19.95 | ₹19.95 | 2.00K (Cr) | |
| ₹19.75 | ₹19.95 | ₹19.00 | ₹19.90 | 18.00K (Cr) | |
| ₹18.15 | ₹18.15 | ₹18.15 | ₹18.15 | 2.00K (Cr) | |
| ₹18.50 | ₹18.50 | ₹18.50 | ₹18.50 | 4.00K (Cr) |
Aatmaja Healthcare Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹18.15 | ₹20.50 | ₹17.80 | ₹18.50 | +1.93% | |
| ₹18.75 | ₹20.50 | ₹16.70 | ₹18.50 | -1.33% | |
| ₹19.00 | ₹20.95 | ₹19.00 | ₹20.95 | +10.26% | |
| ₹21.00 | ₹22.50 | ₹19.20 | ₹20.30 | -3.33% | |
| ₹18.50 | ₹20.30 | ₹18.50 | ₹20.00 | +8.11% | |
| ₹20.00 | ₹21.40 | ₹18.10 | ₹18.35 | -8.25% | |
| ₹21.80 | ₹23.00 | ₹20.50 | ₹21.40 | -1.83% | |
| ₹24.10 | ₹24.65 | ₹20.60 | ₹20.60 | -14.52% | |
| ₹19.50 | ₹25.50 | ₹19.35 | ₹24.25 | +24.36% | |
| ₹20.80 | ₹21.30 | ₹19.05 | ₹19.50 | -6.25% | |
| ₹20.65 | ₹22.10 | ₹18.10 | ₹20.55 | -0.48% | |
| ₹19.10 | ₹22.70 | ₹19.10 | ₹20.75 | +8.64% |
AI Research Briefing
Powered by Gemini · 2026-04-17
Aatmaj Healthcare is an overvalued micro-cap hospital play with unsustainable growth expectations and significant liquidity risk.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Aatmaj Healthcare has been relatively quiet. Filings related to governance and compliance with SEBI regulations were submitted in early April. The trading window for insiders closed on April 1st, ahead of the full year results.
CORE STORY (THE REAL GAME)
This is a micro-cap SME hospital play, banking on the continued growth of the Indian healthcare sector. The market is likely pricing in aggressive growth assumptions, similar to other small-cap healthcare companies.
- High P/E ratio of 52.6x
- Low ROE of 1.29%
- Micro-cap liquidity risk
- Stronger than expected earnings
- Acquisition by a larger player
- Significant government contracts
- Micro-cap SME = liquidity risk
- High P/E, low ROE = valuation stretch
- Single hospital concentration = revenue risk
Promoter holding steady at 63.76%. No FII/DII interest.
Indian healthcare sector is growing, but increased competition could compress margins.
Profit converting to cash is questionable. Free Cash Flow 5Y: ₹3.11 Cr.
In the next 3-6 months, expect a correction as growth slows and the market re-rates the stock. Focus on execution and profitability will be key.
Primary Thesis Risk
Unsustainable growth expectations will lead to a valuation correction.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Aatmaja Healthcare Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Aatmaja Healthcare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of AATMAJ across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Operating Margins (23.26%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Strong Revenue Growth (22.48%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Balanced Promoter Holding (64.33%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (1.41%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (3.56%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 61.59x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-39.39%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (-59.96% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-29.65% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Weak Interest Coverage (1.70x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-7.75 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Aatmaja Healthcare Ltd vs Hospital Peers
Peer Comparison - Hospital
Compare Aatmaja Healthcare Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
31/100 | ₹18.25₹18 | ₹43.73₹43.73 | 61.59Average 61.6 Average | 1.41%Poor 1.41% Poor | 3.56%Poor 3.56% Poor | 0.41Excellent 0.4 Excellent | -29.65%Poor -29.65% Poor | 9.44%Good 9.44% Good | 0.00% | |
Apollo Hospitals Enterprise LimitedApollo Hospital... APOLLOHOSP • 508869 | 62.1/100 | ₹8889.00₹8889 | ₹128448.55₹128448.55 | 61.47Average 61.5 Average | 21.95%Excellent 21.95% Excellent | 19.28%Good 19.28% Good | 0.60Good 0.6 Good | 66.81%Excellent 66.81% Excellent | 19.03%Excellent 19.03% Excellent | 0.22% |
Max Healthcare Institute LimitedMax Healthcare ... MAXHEALTH • 543220 | 56.9/100 | ₹1016.00₹1016 | ₹107422.79₹107422.79 | 73.71Average 73.7 Average | 14.33%Average 14.33% Average | 13.43%Average 13.43% Average | 0.32Excellent 0.3 Excellent | — — | 27.30%Excellent 27.30% Excellent | 0.18% |
Fortis Healthcare LimitedFortis Healthca... FORTIS • 532843 | 56.8/100 | ₹923.95₹924 | ₹73687.64₹73687.64 | 70.32Average 70.3 Average | 11.08%Average 11.08% Average | 12.83%Average 12.83% Average | 0.29Excellent 0.3 Excellent | — — | 17.76%Excellent 17.76% Excellent | 0.10% |
Aster DM Quality Care LimitedAster DM Qualit... ASTERDM • 540975 | 37.2/100 | ₹765.25₹765 | ₹71917.90₹71917.90 | 225.67Average 225.7 Average | 9.70%Poor 9.70% Poor | 11.35%Average 11.35% Average | 0.15Excellent 0.2 Excellent | 21.31%Excellent 21.31% Excellent | -11.61%Poor -11.61% Poor | 0.61% |
Narayana Hrudayalaya Ltd.Narayana Hruday... NH • 539551 | 68.3/100 | ₹1890.10₹1890 | ₹41592.95₹41592.95 | 50.96Average 51.0 Average | 19.74%Good 19.74% Good | 14.53%Average 14.53% Average | 1.07Average 1.1 Average | — — | 25.05%Excellent 25.05% Excellent | 0.22% |
Global Health LimitedGlobal Health L... MEDANTA • 543654 | 59.9/100 | ₹1404.40₹1404 | ₹35993.93₹35993.93 | 64.72Average 64.7 Average | 15.15%Good 15.15% Good | 16.85%Good 16.85% Good | 0.30Excellent 0.3 Excellent | — — | — — | 0.04% |
13.9/100 | ₹772.50₹773 | ₹33947.05₹33947.05 | 166.00Average 166.0 Average | 11.01%Average 11.01% Average | 9.35%Poor 9.35% Poor | 1.44Average 1.4 Average | 3.71%Average 3.71% Average | 24.04%Excellent 24.04% Excellent | 0.00% | |
Dr. Agarwal's Health Care LimitedDr. Agarwal's H... AGARWALEYE • 544350 | 48.5/100 | ₹500.40₹500 | ₹15618.15₹15618.15 | 105.26Average 105.3 Average | 6.84%Poor 6.84% Poor | 10.16%Average 10.16% Average | 0.08Excellent 0.1 Excellent | — — | — — | 0.00% |
Rainbow Childrens Medicare LimitedRainbow Childre... RAINBOW • 543524 | 65.5/100 | ₹1445.20₹1445 | ₹15270.28₹15270.28 | 53.51Average 53.5 Average | 17.86%Good 17.86% Good | 18.10%Good 18.10% Good | 0.00Excellent 0.0 Excellent | — — | — — | 0.23% |
60/100 | ₹298.70₹299 | ₹9829.95₹9829.95 | 52.28Average 52.3 Average | 13.41%Average 13.41% Average | 15.25%Good 15.25% Good | 0.33Excellent 0.3 Excellent | — — | — — | 0.07% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Apollo Hospitals Enterprise Limited share price128448.55 Cr
- Max Healthcare Institute Limited share price107422.79 Cr
- Fortis Healthcare Limited share price73687.64 Cr
- Aster DM Quality Care Limited share price71917.90 Cr
- Narayana Hrudayalaya Ltd. share price41592.95 Cr
Aatmaja Healthcare Ltd Quarterly Performance
Latest quarterly metrics for AATMAJ — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
22.48%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-39.39%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
9.44%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-29.65%
Compounded annual net profit growth over 5 years
Aatmaja Healthcare Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for AATMAJ — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Aatmaja Healthcare Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Aatmaja Healthcare Ltd (AATMAJ) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Aatmaja Healthcare Ltd
About AATMAJ (Aatmaja Healthcare Ltd)
Aatmaja Healthcare Ltd (AATMAJ) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a current ...market capitalisation of ₹43.73 (Cr). Aatmaja Healthcare Ltd has delivered a Return on Equity (ROE) of 1.41% and a ROCE of 3.56%. The debt-to-equity ratio stands at 0.41, reflecting the company's capital structure. Investors tracking AATMAJ share price can monitor key metrics including P/E ratio, promoter holding of 64.33%, and quarterly earnings growth.
Company Details
AATMAJ Share Price: Frequently Asked Questions
What is the current share price of Aatmaja Healthcare Ltd?
Aatmaja Healthcare Ltd (AATMAJ) trades at ₹18.25 on NSE. Market cap ₹43.73 (Cr). Educational data only.
What is the P/E ratio of Aatmaja Healthcare Ltd?
Aatmaja Healthcare Ltd has a P/E of 61.59x vs industry average 48.79x.
What is the Bull Run score for Aatmaja Healthcare Ltd?
Aatmaja Healthcare Ltd has a Bull Run score of 31/100 based on 25+ financial parameters.
Does Aatmaja Healthcare Ltd pay dividends?
Aatmaja Healthcare Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Aatmaja Healthcare Ltd?
Aatmaja Healthcare Ltd has ROE of 1.41%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Aatmaja Healthcare Ltd?
Aatmaja Healthcare Ltd has debt-to-equity of 0.41.
Is Aatmaja Healthcare Ltd a good investment?
Bull Run gives Aatmaja Healthcare Ltd a score of 31/100. This is not investment advice — consult a SEBI-registered advisor.